These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1707291)

  • 21. Antiphospholipid antibodies: a disease marker in 25 patients with antinuclear antibody negative systemic lupus erythematosus (SLE). Comparison with a group of 91 patients with antinuclear antibody positive SLE.
    Meyer O; Piette JC; Bourgeois P; Fallas P; Bletry O; Jungers P; Kahn MF; Godeau P; Ryckewaert A
    J Rheumatol; 1987 Jun; 14(3):502-6. PubMed ID: 3114485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-2 induces activation of coagulation and fibrinolysis: resemblance to the changes seen during experimental endotoxaemia.
    Baars JW; de Boer JP; Wagstaff J; Roem D; Eerenberg-Belmer AJ; Nauta J; Pinedo HM; Hack CE
    Br J Haematol; 1992 Oct; 82(2):295-301. PubMed ID: 1419810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antibodies to various phospholipids in SLE patients with primary antiphospholipid syndrome].
    Reshetniak TM; Boĭtsekhovskaia B; Alekberova ZS; Kalashnikova LA; Mach ES; Zabek Ia
    Klin Med (Mosk); 1999; 77(5):32-7. PubMed ID: 10394784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lupus anticoagulant. A report of 8 cases.
    Agarwal MB; Agarwal UM
    J Assoc Physicians India; 1991 Mar; 39(3):243-5. PubMed ID: 1908857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
    Glas-Greenwalt P; Kant KS; Allen C; Pollak VE
    J Lab Clin Med; 1984 Dec; 104(6):962-76. PubMed ID: 6239000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between antiphospholipid antibodies and cardiac abnormalities in patients with systemic lupus erythematosus.
    Leung WH; Wong KL; Lau CP; Wong CK; Liu HW
    Am J Med; 1990 Oct; 89(4):411-9. PubMed ID: 2121029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between elevated cerebrospinal fluid levels of plasminogen activator inhibitor 1 and neuronal destruction in patients with neuropsychiatric systemic lupus erythematosus.
    Kwieciński J; Kłak M; Trysberg E; Blennow K; Tarkowski A; Jin T
    Arthritis Rheum; 2009 Jul; 60(7):2094-101. PubMed ID: 19565516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes to fibrinolysis in patients with systemic lupus erythematosus are associated with endothelial cell damage and inflammation, but not antiphospholipid antibodies.
    Dhillon PK; Khalafallah AA; Adams MJ
    Blood Coagul Fibrinolysis; 2016 Dec; 27(8):870-875. PubMed ID: 27167859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reassessing the status of antiphospholipid syndrome in systemic lupus erythematosus.
    Vianna JL; Haga HJ; Tripathi P; Cervera R; Khamashta MA; Hughes GR
    Ann Rheum Dis; 1992 Feb; 51(2):160-1. PubMed ID: 1550396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma thrombomodulin and alpha 2-plasmin inhibitor-plasmin complex are elevated in active systemic lupus erythematosus.
    Kawakami M; Kitani A; Hara M; Harigai M; Suzuki K; Kawaguchi Y; Ishii H; Kazama M; Kawagoe M; Nakamura H
    J Rheumatol; 1992 Nov; 19(11):1704-9. PubMed ID: 1337109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myocardial infarction in a young man with systemic lupus erythematosus, deep vein thrombosis, and antibodies to phospholipid.
    Asherson RA; Mackay IR; Harris EN
    Br Heart J; 1986 Aug; 56(2):190-3. PubMed ID: 3089242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
    Meijers JC; Middeldorp S; Tekelenburg W; van den Ende AE; Tans G; Prins MH; Rosing J; Büller HR; Bouma BN
    Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 15 parameters of coagulation and fibrinolysis in children with type I diabetes mellitus (onset period).
    Koert M; Nowak-Göttl U; Kreuz W; Grüttner HP; Kornhuber B; Breddin HK
    Klin Padiatr; 1991; 203(6):429-32. PubMed ID: 1721940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation between lupus anticoagulants and anticardiolipin antibodies in patients with prolonged activated partial thromboplastin times.
    Alving BM; Barr CF; Tang DB
    Am J Med; 1990 Feb; 88(2):112-6. PubMed ID: 2105643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of fibrinolytic parameters and plasminogen activator inhibitor 1 (PAI-1) promoter polymorphism on premature atherosclerosis in SLE patients.
    Bicakcigil M; Tasan D; Tasdelen N; Mutlu N; Yavuz S
    Lupus; 2011 Oct; 20(10):1063-71. PubMed ID: 21719525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiphospholipid antibodies: a risk factor for occlusive ocular vascular disease in systemic lupus erythematosus and the 'primary' antiphospholipid syndrome.
    Asherson RA; Merry P; Acheson JF; Harris EN; Hughes GR
    Ann Rheum Dis; 1989 May; 48(5):358-61. PubMed ID: 2637678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
    Figueredo MA; Rodriguez A; Ruiz-Yagüe M; Romero M; Fernandez-Cruz A; Gomez-de la Concha E; Patiño R
    J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance.
    Love PE; Santoro SA
    Ann Intern Med; 1990 May; 112(9):682-98. PubMed ID: 2110431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum antibodies to distinct epitopes of the tissue-type plasminogen activator (t-PA) in patients with systemic lupus erythematosus.
    Ruiz-Arguelles A; Angles-Cano E; Perez-Romano B; Ruiz-Arguelles GJ; Deleze M; Alarcon-Segovia D; Gaussem P
    Am J Hematol; 1995 Jun; 49(2):109-14. PubMed ID: 7539580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombosis in systemic lupus erythematosus: role of impaired fibrinolysis.
    Dhillon PK; Adams MJ
    Semin Thromb Hemost; 2013 Jun; 39(4):434-40. PubMed ID: 23504607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.